Global Influenza Vaccine Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Influenza Vaccine market size was valued at US$ 7659.5 million in 2022. With growing demand in downstream market, the Influenza Vaccine is forecast to a readjusted size of US$ 11330 million by 2029 with a CAGR of 5.7% during review period.
The research report highlights the growth potential of the global Influenza Vaccine market. Influenza Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Influenza Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Influenza Vaccine market.
Global key players of Vaccine for Influenza include Sanofi, CSL and GSK, etc. The top five players hold a share about 75%. North America is the largest market, has a share about 50%.
Key Features:
The report on Influenza Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Influenza Vaccine market. It may include historical data, market segmentation by Type (e.g., Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Influenza Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Influenza Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Influenza Vaccine industry. This include advancements in Influenza Vaccine technology, Influenza Vaccine new entrants, Influenza Vaccine new investment, and other innovations that are shaping the future of Influenza Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Influenza Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Influenza Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Influenza Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Influenza Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Influenza Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Influenza Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Influenza Vaccine market.
Market Segmentation:
Influenza Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Influenza Vaccine market?
What factors are driving Influenza Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Influenza Vaccine market opportunities vary by end market size?
How does Influenza Vaccine break out type, application?
According to our LPI (LP Information) latest study, the global Influenza Vaccine market size was valued at US$ 7659.5 million in 2022. With growing demand in downstream market, the Influenza Vaccine is forecast to a readjusted size of US$ 11330 million by 2029 with a CAGR of 5.7% during review period.
The research report highlights the growth potential of the global Influenza Vaccine market. Influenza Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Influenza Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Influenza Vaccine market.
Global key players of Vaccine for Influenza include Sanofi, CSL and GSK, etc. The top five players hold a share about 75%. North America is the largest market, has a share about 50%.
Key Features:
The report on Influenza Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Influenza Vaccine market. It may include historical data, market segmentation by Type (e.g., Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Influenza Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Influenza Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Influenza Vaccine industry. This include advancements in Influenza Vaccine technology, Influenza Vaccine new entrants, Influenza Vaccine new investment, and other innovations that are shaping the future of Influenza Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Influenza Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Influenza Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Influenza Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Influenza Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Influenza Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Influenza Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Influenza Vaccine market.
Market Segmentation:
Influenza Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Trivalent Influenza Vaccine
- Quadrivalent Influenza Vaccine
- 6 Months to 3 Years
- > 3 Years
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- CSL
- GSK
- Viatris
- AstraZeneca
- Hualan Bio
- Changchun Institute of Biological
- Sinovac
- BCHT
- Jiangsu GDK
- KM Biologics
What is the 10-year outlook for the global Influenza Vaccine market?
What factors are driving Influenza Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Influenza Vaccine market opportunities vary by end market size?
How does Influenza Vaccine break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Influenza Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Influenza Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Influenza Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Influenza Vaccine Segment by Type
2.2.1 Trivalent Influenza Vaccine
2.2.2 Quadrivalent Influenza Vaccine
2.3 Influenza Vaccine Sales by Type
2.3.1 Global Influenza Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Influenza Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Influenza Vaccine Sale Price by Type (2018-2023)
2.4 Influenza Vaccine Segment by Application
2.4.1 6 Months to 3 Years
2.4.2 > 3 Years
2.5 Influenza Vaccine Sales by Application
2.5.1 Global Influenza Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Influenza Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Influenza Vaccine Sale Price by Application (2018-2023)
3 GLOBAL INFLUENZA VACCINE BY COMPANY
3.1 Global Influenza Vaccine Breakdown Data by Company
3.1.1 Global Influenza Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Influenza Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Influenza Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Influenza Vaccine Revenue by Company (2018-2023)
3.2.2 Global Influenza Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Influenza Vaccine Sale Price by Company
3.4 Key Manufacturers Influenza Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Influenza Vaccine Product Location Distribution
3.4.2 Players Influenza Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INFLUENZA VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Influenza Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Influenza Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Influenza Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Influenza Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Influenza Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Influenza Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Influenza Vaccine Sales Growth
4.4 APAC Influenza Vaccine Sales Growth
4.5 Europe Influenza Vaccine Sales Growth
4.6 Middle East & Africa Influenza Vaccine Sales Growth
5 AMERICAS
5.1 Americas Influenza Vaccine Sales by Country
5.1.1 Americas Influenza Vaccine Sales by Country (2018-2023)
5.1.2 Americas Influenza Vaccine Revenue by Country (2018-2023)
5.2 Americas Influenza Vaccine Sales by Type
5.3 Americas Influenza Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Influenza Vaccine Sales by Region
6.1.1 APAC Influenza Vaccine Sales by Region (2018-2023)
6.1.2 APAC Influenza Vaccine Revenue by Region (2018-2023)
6.2 APAC Influenza Vaccine Sales by Type
6.3 APAC Influenza Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Influenza Vaccine by Country
7.1.1 Europe Influenza Vaccine Sales by Country (2018-2023)
7.1.2 Europe Influenza Vaccine Revenue by Country (2018-2023)
7.2 Europe Influenza Vaccine Sales by Type
7.3 Europe Influenza Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Influenza Vaccine by Country
8.1.1 Middle East & Africa Influenza Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Influenza Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Influenza Vaccine Sales by Type
8.3 Middle East & Africa Influenza Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Influenza Vaccine
10.3 Manufacturing Process Analysis of Influenza Vaccine
10.4 Industry Chain Structure of Influenza Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Influenza Vaccine Distributors
11.3 Influenza Vaccine Customer
12 WORLD FORECAST REVIEW FOR INFLUENZA VACCINE BY GEOGRAPHIC REGION
12.1 Global Influenza Vaccine Market Size Forecast by Region
12.1.1 Global Influenza Vaccine Forecast by Region (2024-2029)
12.1.2 Global Influenza Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Influenza Vaccine Forecast by Type
12.7 Global Influenza Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Influenza Vaccine Product Portfolios and Specifications
13.1.3 Sanofi Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Influenza Vaccine Product Portfolios and Specifications
13.2.3 CSL Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Influenza Vaccine Product Portfolios and Specifications
13.3.3 GSK Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Viatris
13.4.1 Viatris Company Information
13.4.2 Viatris Influenza Vaccine Product Portfolios and Specifications
13.4.3 Viatris Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Viatris Main Business Overview
13.4.5 Viatris Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Influenza Vaccine Product Portfolios and Specifications
13.5.3 AstraZeneca Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Hualan Bio
13.6.1 Hualan Bio Company Information
13.6.2 Hualan Bio Influenza Vaccine Product Portfolios and Specifications
13.6.3 Hualan Bio Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Hualan Bio Main Business Overview
13.6.5 Hualan Bio Latest Developments
13.7 Changchun Institute of Biological
13.7.1 Changchun Institute of Biological Company Information
13.7.2 Changchun Institute of Biological Influenza Vaccine Product Portfolios and Specifications
13.7.3 Changchun Institute of Biological Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Changchun Institute of Biological Main Business Overview
13.7.5 Changchun Institute of Biological Latest Developments
13.8 Sinovac
13.8.1 Sinovac Company Information
13.8.2 Sinovac Influenza Vaccine Product Portfolios and Specifications
13.8.3 Sinovac Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Sinovac Main Business Overview
13.8.5 Sinovac Latest Developments
13.9 BCHT
13.9.1 BCHT Company Information
13.9.2 BCHT Influenza Vaccine Product Portfolios and Specifications
13.9.3 BCHT Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 BCHT Main Business Overview
13.9.5 BCHT Latest Developments
13.10 Jiangsu GDK
13.10.1 Jiangsu GDK Company Information
13.10.2 Jiangsu GDK Influenza Vaccine Product Portfolios and Specifications
13.10.3 Jiangsu GDK Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Jiangsu GDK Main Business Overview
13.10.5 Jiangsu GDK Latest Developments
13.11 KM Biologics
13.11.1 KM Biologics Company Information
13.11.2 KM Biologics Influenza Vaccine Product Portfolios and Specifications
13.11.3 KM Biologics Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 KM Biologics Main Business Overview
13.11.5 KM Biologics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Influenza Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Influenza Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Influenza Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Influenza Vaccine Segment by Type
2.2.1 Trivalent Influenza Vaccine
2.2.2 Quadrivalent Influenza Vaccine
2.3 Influenza Vaccine Sales by Type
2.3.1 Global Influenza Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Influenza Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Influenza Vaccine Sale Price by Type (2018-2023)
2.4 Influenza Vaccine Segment by Application
2.4.1 6 Months to 3 Years
2.4.2 > 3 Years
2.5 Influenza Vaccine Sales by Application
2.5.1 Global Influenza Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Influenza Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Influenza Vaccine Sale Price by Application (2018-2023)
3 GLOBAL INFLUENZA VACCINE BY COMPANY
3.1 Global Influenza Vaccine Breakdown Data by Company
3.1.1 Global Influenza Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Influenza Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Influenza Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Influenza Vaccine Revenue by Company (2018-2023)
3.2.2 Global Influenza Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Influenza Vaccine Sale Price by Company
3.4 Key Manufacturers Influenza Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Influenza Vaccine Product Location Distribution
3.4.2 Players Influenza Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INFLUENZA VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Influenza Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Influenza Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Influenza Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Influenza Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Influenza Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Influenza Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Influenza Vaccine Sales Growth
4.4 APAC Influenza Vaccine Sales Growth
4.5 Europe Influenza Vaccine Sales Growth
4.6 Middle East & Africa Influenza Vaccine Sales Growth
5 AMERICAS
5.1 Americas Influenza Vaccine Sales by Country
5.1.1 Americas Influenza Vaccine Sales by Country (2018-2023)
5.1.2 Americas Influenza Vaccine Revenue by Country (2018-2023)
5.2 Americas Influenza Vaccine Sales by Type
5.3 Americas Influenza Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Influenza Vaccine Sales by Region
6.1.1 APAC Influenza Vaccine Sales by Region (2018-2023)
6.1.2 APAC Influenza Vaccine Revenue by Region (2018-2023)
6.2 APAC Influenza Vaccine Sales by Type
6.3 APAC Influenza Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Influenza Vaccine by Country
7.1.1 Europe Influenza Vaccine Sales by Country (2018-2023)
7.1.2 Europe Influenza Vaccine Revenue by Country (2018-2023)
7.2 Europe Influenza Vaccine Sales by Type
7.3 Europe Influenza Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Influenza Vaccine by Country
8.1.1 Middle East & Africa Influenza Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Influenza Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Influenza Vaccine Sales by Type
8.3 Middle East & Africa Influenza Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Influenza Vaccine
10.3 Manufacturing Process Analysis of Influenza Vaccine
10.4 Industry Chain Structure of Influenza Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Influenza Vaccine Distributors
11.3 Influenza Vaccine Customer
12 WORLD FORECAST REVIEW FOR INFLUENZA VACCINE BY GEOGRAPHIC REGION
12.1 Global Influenza Vaccine Market Size Forecast by Region
12.1.1 Global Influenza Vaccine Forecast by Region (2024-2029)
12.1.2 Global Influenza Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Influenza Vaccine Forecast by Type
12.7 Global Influenza Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Influenza Vaccine Product Portfolios and Specifications
13.1.3 Sanofi Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Influenza Vaccine Product Portfolios and Specifications
13.2.3 CSL Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Influenza Vaccine Product Portfolios and Specifications
13.3.3 GSK Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Viatris
13.4.1 Viatris Company Information
13.4.2 Viatris Influenza Vaccine Product Portfolios and Specifications
13.4.3 Viatris Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Viatris Main Business Overview
13.4.5 Viatris Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Influenza Vaccine Product Portfolios and Specifications
13.5.3 AstraZeneca Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Hualan Bio
13.6.1 Hualan Bio Company Information
13.6.2 Hualan Bio Influenza Vaccine Product Portfolios and Specifications
13.6.3 Hualan Bio Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Hualan Bio Main Business Overview
13.6.5 Hualan Bio Latest Developments
13.7 Changchun Institute of Biological
13.7.1 Changchun Institute of Biological Company Information
13.7.2 Changchun Institute of Biological Influenza Vaccine Product Portfolios and Specifications
13.7.3 Changchun Institute of Biological Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Changchun Institute of Biological Main Business Overview
13.7.5 Changchun Institute of Biological Latest Developments
13.8 Sinovac
13.8.1 Sinovac Company Information
13.8.2 Sinovac Influenza Vaccine Product Portfolios and Specifications
13.8.3 Sinovac Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Sinovac Main Business Overview
13.8.5 Sinovac Latest Developments
13.9 BCHT
13.9.1 BCHT Company Information
13.9.2 BCHT Influenza Vaccine Product Portfolios and Specifications
13.9.3 BCHT Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 BCHT Main Business Overview
13.9.5 BCHT Latest Developments
13.10 Jiangsu GDK
13.10.1 Jiangsu GDK Company Information
13.10.2 Jiangsu GDK Influenza Vaccine Product Portfolios and Specifications
13.10.3 Jiangsu GDK Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Jiangsu GDK Main Business Overview
13.10.5 Jiangsu GDK Latest Developments
13.11 KM Biologics
13.11.1 KM Biologics Company Information
13.11.2 KM Biologics Influenza Vaccine Product Portfolios and Specifications
13.11.3 KM Biologics Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 KM Biologics Main Business Overview
13.11.5 KM Biologics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Influenza Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Influenza Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Trivalent Influenza Vaccine
Table 4. Major Players of Quadrivalent Influenza Vaccine
Table 5. Global Influenza Vaccine Sales by Type (2018-2023) & (M Units)
Table 6. Global Influenza Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Influenza Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Influenza Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Influenza Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Influenza Vaccine Sales by Application (2018-2023) & (M Units)
Table 11. Global Influenza Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Influenza Vaccine Revenue by Application (2018-2023)
Table 13. Global Influenza Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Influenza Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Influenza Vaccine Sales by Company (2018-2023) & (M Units)
Table 16. Global Influenza Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Influenza Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Influenza Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Influenza Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Influenza Vaccine Producing Area Distribution and Sales Area
Table 21. Players Influenza Vaccine Products Offered
Table 22. Influenza Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Influenza Vaccine Sales by Geographic Region (2018-2023) & (M Units)
Table 26. Global Influenza Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Influenza Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Influenza Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Influenza Vaccine Sales by Country/Region (2018-2023) & (M Units)
Table 30. Global Influenza Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Influenza Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Influenza Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Influenza Vaccine Sales by Country (2018-2023) & (M Units)
Table 34. Americas Influenza Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Influenza Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Influenza Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Influenza Vaccine Sales by Type (2018-2023) & (M Units)
Table 38. Americas Influenza Vaccine Sales by Application (2018-2023) & (M Units)
Table 39. APAC Influenza Vaccine Sales by Region (2018-2023) & (M Units)
Table 40. APAC Influenza Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Influenza Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Influenza Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Influenza Vaccine Sales by Type (2018-2023) & (M Units)
Table 44. APAC Influenza Vaccine Sales by Application (2018-2023) & (M Units)
Table 45. Europe Influenza Vaccine Sales by Country (2018-2023) & (M Units)
Table 46. Europe Influenza Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Influenza Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Influenza Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Influenza Vaccine Sales by Type (2018-2023) & (M Units)
Table 50. Europe Influenza Vaccine Sales by Application (2018-2023) & (M Units)
Table 51. Middle East & Africa Influenza Vaccine Sales by Country (2018-2023) & (M Units)
Table 52. Middle East & Africa Influenza Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Influenza Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Influenza Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Influenza Vaccine Sales by Type (2018-2023) & (M Units)
Table 56. Middle East & Africa Influenza Vaccine Sales by Application (2018-2023) & (M Units)
Table 57. Key Market Drivers & Growth Opportunities of Influenza Vaccine
Table 58. Key Market Challenges & Risks of Influenza Vaccine
Table 59. Key Industry Trends of Influenza Vaccine
Table 60. Influenza Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Influenza Vaccine Distributors List
Table 63. Influenza Vaccine Customer List
Table 64. Global Influenza Vaccine Sales Forecast by Region (2024-2029) & (M Units)
Table 65. Global Influenza Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Influenza Vaccine Sales Forecast by Country (2024-2029) & (M Units)
Table 67. Americas Influenza Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Influenza Vaccine Sales Forecast by Region (2024-2029) & (M Units)
Table 69. APAC Influenza Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Influenza Vaccine Sales Forecast by Country (2024-2029) & (M Units)
Table 71. Europe Influenza Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Influenza Vaccine Sales Forecast by Country (2024-2029) & (M Units)
Table 73. Middle East & Africa Influenza Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Influenza Vaccine Sales Forecast by Type (2024-2029) & (M Units)
Table 75. Global Influenza Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Influenza Vaccine Sales Forecast by Application (2024-2029) & (M Units)
Table 77. Global Influenza Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Sanofi Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Influenza Vaccine Product Portfolios and Specifications
Table 80. Sanofi Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Sanofi Main Business
Table 82. Sanofi Latest Developments
Table 83. CSL Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. CSL Influenza Vaccine Product Portfolios and Specifications
Table 85. CSL Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. CSL Main Business
Table 87. CSL Latest Developments
Table 88. GSK Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. GSK Influenza Vaccine Product Portfolios and Specifications
Table 90. GSK Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. GSK Main Business
Table 92. GSK Latest Developments
Table 93. Viatris Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Viatris Influenza Vaccine Product Portfolios and Specifications
Table 95. Viatris Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Viatris Main Business
Table 97. Viatris Latest Developments
Table 98. AstraZeneca Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. AstraZeneca Influenza Vaccine Product Portfolios and Specifications
Table 100. AstraZeneca Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. AstraZeneca Main Business
Table 102. AstraZeneca Latest Developments
Table 103. Hualan Bio Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Hualan Bio Influenza Vaccine Product Portfolios and Specifications
Table 105. Hualan Bio Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Hualan Bio Main Business
Table 107. Hualan Bio Latest Developments
Table 108. Changchun Institute of Biological Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Changchun Institute of Biological Influenza Vaccine Product Portfolios and Specifications
Table 110. Changchun Institute of Biological Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Changchun Institute of Biological Main Business
Table 112. Changchun Institute of Biological Latest Developments
Table 113. Sinovac Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Sinovac Influenza Vaccine Product Portfolios and Specifications
Table 115. Sinovac Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Sinovac Main Business
Table 117. Sinovac Latest Developments
Table 118. BCHT Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. BCHT Influenza Vaccine Product Portfolios and Specifications
Table 120. BCHT Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. BCHT Main Business
Table 122. BCHT Latest Developments
Table 123. Jiangsu GDK Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. Jiangsu GDK Influenza Vaccine Product Portfolios and Specifications
Table 125. Jiangsu GDK Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Jiangsu GDK Main Business
Table 127. Jiangsu GDK Latest Developments
Table 128. KM Biologics Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. KM Biologics Influenza Vaccine Product Portfolios and Specifications
Table 130. KM Biologics Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. KM Biologics Main Business
Table 132. KM Biologics Latest Developments
Table 1. Influenza Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Influenza Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Trivalent Influenza Vaccine
Table 4. Major Players of Quadrivalent Influenza Vaccine
Table 5. Global Influenza Vaccine Sales by Type (2018-2023) & (M Units)
Table 6. Global Influenza Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Influenza Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Influenza Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Influenza Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Influenza Vaccine Sales by Application (2018-2023) & (M Units)
Table 11. Global Influenza Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Influenza Vaccine Revenue by Application (2018-2023)
Table 13. Global Influenza Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Influenza Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Influenza Vaccine Sales by Company (2018-2023) & (M Units)
Table 16. Global Influenza Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Influenza Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Influenza Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Influenza Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Influenza Vaccine Producing Area Distribution and Sales Area
Table 21. Players Influenza Vaccine Products Offered
Table 22. Influenza Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Influenza Vaccine Sales by Geographic Region (2018-2023) & (M Units)
Table 26. Global Influenza Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Influenza Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Influenza Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Influenza Vaccine Sales by Country/Region (2018-2023) & (M Units)
Table 30. Global Influenza Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Influenza Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Influenza Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Influenza Vaccine Sales by Country (2018-2023) & (M Units)
Table 34. Americas Influenza Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Influenza Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Influenza Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Influenza Vaccine Sales by Type (2018-2023) & (M Units)
Table 38. Americas Influenza Vaccine Sales by Application (2018-2023) & (M Units)
Table 39. APAC Influenza Vaccine Sales by Region (2018-2023) & (M Units)
Table 40. APAC Influenza Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Influenza Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Influenza Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Influenza Vaccine Sales by Type (2018-2023) & (M Units)
Table 44. APAC Influenza Vaccine Sales by Application (2018-2023) & (M Units)
Table 45. Europe Influenza Vaccine Sales by Country (2018-2023) & (M Units)
Table 46. Europe Influenza Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Influenza Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Influenza Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Influenza Vaccine Sales by Type (2018-2023) & (M Units)
Table 50. Europe Influenza Vaccine Sales by Application (2018-2023) & (M Units)
Table 51. Middle East & Africa Influenza Vaccine Sales by Country (2018-2023) & (M Units)
Table 52. Middle East & Africa Influenza Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Influenza Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Influenza Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Influenza Vaccine Sales by Type (2018-2023) & (M Units)
Table 56. Middle East & Africa Influenza Vaccine Sales by Application (2018-2023) & (M Units)
Table 57. Key Market Drivers & Growth Opportunities of Influenza Vaccine
Table 58. Key Market Challenges & Risks of Influenza Vaccine
Table 59. Key Industry Trends of Influenza Vaccine
Table 60. Influenza Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Influenza Vaccine Distributors List
Table 63. Influenza Vaccine Customer List
Table 64. Global Influenza Vaccine Sales Forecast by Region (2024-2029) & (M Units)
Table 65. Global Influenza Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Influenza Vaccine Sales Forecast by Country (2024-2029) & (M Units)
Table 67. Americas Influenza Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Influenza Vaccine Sales Forecast by Region (2024-2029) & (M Units)
Table 69. APAC Influenza Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Influenza Vaccine Sales Forecast by Country (2024-2029) & (M Units)
Table 71. Europe Influenza Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Influenza Vaccine Sales Forecast by Country (2024-2029) & (M Units)
Table 73. Middle East & Africa Influenza Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Influenza Vaccine Sales Forecast by Type (2024-2029) & (M Units)
Table 75. Global Influenza Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Influenza Vaccine Sales Forecast by Application (2024-2029) & (M Units)
Table 77. Global Influenza Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Sanofi Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Influenza Vaccine Product Portfolios and Specifications
Table 80. Sanofi Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Sanofi Main Business
Table 82. Sanofi Latest Developments
Table 83. CSL Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. CSL Influenza Vaccine Product Portfolios and Specifications
Table 85. CSL Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. CSL Main Business
Table 87. CSL Latest Developments
Table 88. GSK Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. GSK Influenza Vaccine Product Portfolios and Specifications
Table 90. GSK Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. GSK Main Business
Table 92. GSK Latest Developments
Table 93. Viatris Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Viatris Influenza Vaccine Product Portfolios and Specifications
Table 95. Viatris Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Viatris Main Business
Table 97. Viatris Latest Developments
Table 98. AstraZeneca Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. AstraZeneca Influenza Vaccine Product Portfolios and Specifications
Table 100. AstraZeneca Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. AstraZeneca Main Business
Table 102. AstraZeneca Latest Developments
Table 103. Hualan Bio Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Hualan Bio Influenza Vaccine Product Portfolios and Specifications
Table 105. Hualan Bio Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Hualan Bio Main Business
Table 107. Hualan Bio Latest Developments
Table 108. Changchun Institute of Biological Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Changchun Institute of Biological Influenza Vaccine Product Portfolios and Specifications
Table 110. Changchun Institute of Biological Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Changchun Institute of Biological Main Business
Table 112. Changchun Institute of Biological Latest Developments
Table 113. Sinovac Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Sinovac Influenza Vaccine Product Portfolios and Specifications
Table 115. Sinovac Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Sinovac Main Business
Table 117. Sinovac Latest Developments
Table 118. BCHT Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. BCHT Influenza Vaccine Product Portfolios and Specifications
Table 120. BCHT Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. BCHT Main Business
Table 122. BCHT Latest Developments
Table 123. Jiangsu GDK Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. Jiangsu GDK Influenza Vaccine Product Portfolios and Specifications
Table 125. Jiangsu GDK Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Jiangsu GDK Main Business
Table 127. Jiangsu GDK Latest Developments
Table 128. KM Biologics Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. KM Biologics Influenza Vaccine Product Portfolios and Specifications
Table 130. KM Biologics Influenza Vaccine Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. KM Biologics Main Business
Table 132. KM Biologics Latest Developments
LIST OF FIGURES
Figure 1. Picture of Influenza Vaccine
Figure 2. Influenza Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Influenza Vaccine Sales Growth Rate 2018-2029 (M Units)
Figure 7. Global Influenza Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Influenza Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Trivalent Influenza Vaccine
Figure 10. Product Picture of Quadrivalent Influenza Vaccine
Figure 11. Global Influenza Vaccine Sales Market Share by Type in 2022
Figure 12. Global Influenza Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Influenza Vaccine Consumed in 6 Months to 3 Years
Figure 14. Global Influenza Vaccine Market: 6 Months to 3 Years (2018-2023) & (M Units)
Figure 15. Influenza Vaccine Consumed in > 3 Years
Figure 16. Global Influenza Vaccine Market: > 3 Years (2018-2023) & (M Units)
Figure 17. Global Influenza Vaccine Sales Market Share by Application (2022)
Figure 18. Global Influenza Vaccine Revenue Market Share by Application in 2022
Figure 19. Influenza Vaccine Sales Market by Company in 2022 (M Units)
Figure 20. Global Influenza Vaccine Sales Market Share by Company in 2022
Figure 21. Influenza Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Influenza Vaccine Revenue Market Share by Company in 2022
Figure 23. Global Influenza Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Influenza Vaccine Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Influenza Vaccine Sales 2018-2023 (M Units)
Figure 26. Americas Influenza Vaccine Revenue 2018-2023 ($ Millions)
Figure 27. APAC Influenza Vaccine Sales 2018-2023 (M Units)
Figure 28. APAC Influenza Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. Europe Influenza Vaccine Sales 2018-2023 (M Units)
Figure 30. Europe Influenza Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Influenza Vaccine Sales 2018-2023 (M Units)
Figure 32. Middle East & Africa Influenza Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Americas Influenza Vaccine Sales Market Share by Country in 2022
Figure 34. Americas Influenza Vaccine Revenue Market Share by Country in 2022
Figure 35. Americas Influenza Vaccine Sales Market Share by Type (2018-2023)
Figure 36. Americas Influenza Vaccine Sales Market Share by Application (2018-2023)
Figure 37. United States Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Influenza Vaccine Sales Market Share by Region in 2022
Figure 42. APAC Influenza Vaccine Revenue Market Share by Regions in 2022
Figure 43. APAC Influenza Vaccine Sales Market Share by Type (2018-2023)
Figure 44. APAC Influenza Vaccine Sales Market Share by Application (2018-2023)
Figure 45. China Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Influenza Vaccine Sales Market Share by Country in 2022
Figure 53. Europe Influenza Vaccine Revenue Market Share by Country in 2022
Figure 54. Europe Influenza Vaccine Sales Market Share by Type (2018-2023)
Figure 55. Europe Influenza Vaccine Sales Market Share by Application (2018-2023)
Figure 56. Germany Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Influenza Vaccine Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Influenza Vaccine Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Influenza Vaccine Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Influenza Vaccine Sales Market Share by Application (2018-2023)
Figure 65. Egypt Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Influenza Vaccine in 2022
Figure 71. Manufacturing Process Analysis of Influenza Vaccine
Figure 72. Industry Chain Structure of Influenza Vaccine
Figure 73. Channels of Distribution
Figure 74. Global Influenza Vaccine Sales Market Forecast by Region (2024-2029)
Figure 75. Global Influenza Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Influenza Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Influenza Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Influenza Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Influenza Vaccine Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Influenza Vaccine
Figure 2. Influenza Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Influenza Vaccine Sales Growth Rate 2018-2029 (M Units)
Figure 7. Global Influenza Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Influenza Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Trivalent Influenza Vaccine
Figure 10. Product Picture of Quadrivalent Influenza Vaccine
Figure 11. Global Influenza Vaccine Sales Market Share by Type in 2022
Figure 12. Global Influenza Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Influenza Vaccine Consumed in 6 Months to 3 Years
Figure 14. Global Influenza Vaccine Market: 6 Months to 3 Years (2018-2023) & (M Units)
Figure 15. Influenza Vaccine Consumed in > 3 Years
Figure 16. Global Influenza Vaccine Market: > 3 Years (2018-2023) & (M Units)
Figure 17. Global Influenza Vaccine Sales Market Share by Application (2022)
Figure 18. Global Influenza Vaccine Revenue Market Share by Application in 2022
Figure 19. Influenza Vaccine Sales Market by Company in 2022 (M Units)
Figure 20. Global Influenza Vaccine Sales Market Share by Company in 2022
Figure 21. Influenza Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Influenza Vaccine Revenue Market Share by Company in 2022
Figure 23. Global Influenza Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Influenza Vaccine Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Influenza Vaccine Sales 2018-2023 (M Units)
Figure 26. Americas Influenza Vaccine Revenue 2018-2023 ($ Millions)
Figure 27. APAC Influenza Vaccine Sales 2018-2023 (M Units)
Figure 28. APAC Influenza Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. Europe Influenza Vaccine Sales 2018-2023 (M Units)
Figure 30. Europe Influenza Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Influenza Vaccine Sales 2018-2023 (M Units)
Figure 32. Middle East & Africa Influenza Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Americas Influenza Vaccine Sales Market Share by Country in 2022
Figure 34. Americas Influenza Vaccine Revenue Market Share by Country in 2022
Figure 35. Americas Influenza Vaccine Sales Market Share by Type (2018-2023)
Figure 36. Americas Influenza Vaccine Sales Market Share by Application (2018-2023)
Figure 37. United States Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Influenza Vaccine Sales Market Share by Region in 2022
Figure 42. APAC Influenza Vaccine Revenue Market Share by Regions in 2022
Figure 43. APAC Influenza Vaccine Sales Market Share by Type (2018-2023)
Figure 44. APAC Influenza Vaccine Sales Market Share by Application (2018-2023)
Figure 45. China Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Influenza Vaccine Sales Market Share by Country in 2022
Figure 53. Europe Influenza Vaccine Revenue Market Share by Country in 2022
Figure 54. Europe Influenza Vaccine Sales Market Share by Type (2018-2023)
Figure 55. Europe Influenza Vaccine Sales Market Share by Application (2018-2023)
Figure 56. Germany Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Influenza Vaccine Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Influenza Vaccine Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Influenza Vaccine Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Influenza Vaccine Sales Market Share by Application (2018-2023)
Figure 65. Egypt Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Influenza Vaccine in 2022
Figure 71. Manufacturing Process Analysis of Influenza Vaccine
Figure 72. Industry Chain Structure of Influenza Vaccine
Figure 73. Channels of Distribution
Figure 74. Global Influenza Vaccine Sales Market Forecast by Region (2024-2029)
Figure 75. Global Influenza Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Influenza Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Influenza Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Influenza Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Influenza Vaccine Revenue Market Share Forecast by Application (2024-2029)
